MedTrace Logo

Prediction of SSRI Treatment in Major Depression.

NCT03670823 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-06-07

No results posted yet for this study

Summary

This project will combine the data collected from EEG, Eye tracking, structural and functional MRI scans and neuropsychological performance from patients with major depression receiving SSRI treatment. The purpose of this research is to predict the success of the SSRI treatment and to categorize patients into sub-groups according to similar patterns of brain activation to personalize treatment.

Conditions

Interventions

DEVICE

SIEMENS PRISMA MRI

Collect data on brain activation from different methods

Sponsors & Collaborators

  • Sheba Medical Center

    collaborator OTHER_GOV

  • Hebrew University of Jerusalem

    collaborator OTHER

  • ElMindA Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2020-10-01
Completion
2020-10-01
FDA Device
Yes

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03670823 on ClinicalTrials.gov